U of Manchester to Run Abcodia Lung Cancer Collaboration From New $27M Biomarker Discovery Center

Aug 20, 2015

|

Premium

NEW YORK (GenomeWeb) – The University of Manchester is collaborating with UK-based diagnostics firm Abcodia to identify protein biomarkers for risk stratification and early detection of lung cancer.

The effort is one of a series of biomarker development projects the university will run out of the Stoller Biomarker Discovery Centre that it plans to open next year supported by £17 million ($27 million) in funding largely from the UK's Medical Research Council.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Stroma Liquid Biopsy, a pan-cancer biomarker panel of dysregulation derived from blood

Lipid Removal Sample Prep for Cell Response Applications

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

Menu